Ampiroxicam

安吡昔康

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameAmpiroxicam
Drug Alias NameAmpiroxicamum氨必罗赫安碧罗康NacylFlucam +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclooxygenases inhibitors
TargetsCyclooxygenases
Therapy Area/IndicationsPainInflammation
Global Approved IndicationsPainInflammation
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date1993/10/01
Country/TerritoryJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesPfizer Inc
Inactive CompaniesN/A
Active IndicationsPainInflammation
Inactive IndicationsN/A

Other Information

ATC CodeM01AC
Related LinksWikipediaKEGG